Trial Profile
Z-206 Phase III Clinical Trial - Investigation on the remission-maintaining effect in patients with ulcerative colitis in remission phase -
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Sep 2022
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary) ; Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Zeria
- 20 May 2016 New trial record